TECHNICAL ANALYSIS
IFF
International Flavors & Fragrances
TECHNICAL RATING
TECHNICAL SCORE
87 / 100
Summary
Price sits 7.9% above its 20-day (87.27), 9.9% above its 50-day (85.69) and 21.8% above its 200-day (77.32); a Golden cross is in place. MACD is above its signal line (2.3126 vs 1.5282) and RSI(14) is 80.4, an overbought reading, so momentum is confirming the uptrend while signaling extreme near-term strength. The stock is trading inside the Bollinger bands and daily volume is under its 20-day average, which reduces conviction behind any immediate breakout. What would change this picture is a sustained return toward the 20-day moving average or a material uptick in volume supporting higher prices.
Price & Moving Averages
Volume
RSI (14)
MACD (12/26/9)
Formula & Methodology
Short-term trendPrice vs. 20-day moving average (weight 10%)
Intermediate trendPrice vs. 50-day moving average (weight 15%)
Long-term regimePrice vs. 200-day moving average (weight 25%)
Cross state50/200 Golden or Death cross (weight 10%)
Momentum + trendMACD 12/26/9 vs signal line (weight 15%)
Momentum bandsRSI (14) state (weight 10%)
VolatilityBollinger-band position (weight 5%)
ConfirmationVolume vs 20-day average (weight 10%)
Rating ruleFormula: the Technical Score is a weighted composite of eight inputs. Trend inputs — price vs. the 20-day (10%), 50-day (15%), and 200-day (25%) moving averages, and the 50/200 Golden or Death cross state (10%) — carry roughly 60% of the weight. Momentum inputs — MACD (12/26/9) vs. its signal line (15%) and RSI (14) state (10%) — carry 25%. Bollinger-band position (5%) and volume vs. the 20-day average (10%) round out the remainder. Each input contributes +1, 0, or -1, weights are re-normalized when a component is unavailable, and the weighted sum is thresholded at +/-0.45 to Bullish, Neutral, or Bearish.
Data Source
Market data sourced from Tiingo. End-of-day prices and volume power the charts and indicators (MA20/50/200, RSI, MACD, Bollinger Bands, Volume) on this page. This page is informational analysis, not investment advice. See Financial Disclaimer.